ION PACLITAXEL-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2011-01855
- Event Type
- Injury
- Date Received
- May 24, 2011
- Date of Event
- March 25, 2011
- Report Date
- April 25, 2011
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- NIQ
- PMA / PMN Number
- P100023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WA, US
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS A COMBINATION PRODUCT. PATIENT IDENTIFIER - (B)(6). DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
(B)(4). IT WAS REPORTED THAT POST A CORONARY STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED MYOCARDIAL INFARCTION. THE 90% STENOSED TARGET LESION LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING(LAD) WAS 3.5MM DIAMETER AND 16MM LONG. THE LESION WAS TREATED WITH PREDILATION AND PLACEMENT OF A 3.5X20MM STUDY STENT. RESIDUAL STENOSIS WAS 0%. THE PATIENT WAS DISCHARGED 1 DAY LATER ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2011, THE PATIENT WAS ADMITTED WITH MYOCARDIAL INFARCTION (MI). ANGIOGRAPHY WAS PERFORMED BUT, NO REVASCULARIZATION DONE. THE LOCATION OF THE MI WAS REPORTED AS "NOT IDENTIFIABLE." THE PATIENT WAS DISCHARGED 1 DAY LATER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ION PACLITAXEL-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - MAPLE GROVE | UNK692 | 11068823 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Other |